- Global Clearinghouse of Bioequivalence Certificates sjc 2009-06-15 01:02
- FDA's site Helmut 2009-06-12 14:48
- IND, NDA, ANDA Dr.Niraj Limbachiya 2009-05-30 04:30
- Guidance Documents Helmut 2006-01-20 23:28
- alternative sources… Helmut 2007-02-20 16:16
- requests for update Helmut 2007-08-14 20:30
- ▌Regulatory requirements▐ Helmut 2007-09-14 13:18
- Redesign of FDA’s website :-( Helmut 2009-06-08 15:24
- Nations w/ Mandated Bioequivalence sjc 2009-06-06 02:13
- India / Latin America Helmut 2009-06-06 02:36
- India / Latin America sjc 2009-06-06 17:54
- India / Latin America Helmut 2009-06-06 02:36
- MHRA audit vinayajadav 2009-05-30 08:16
- MHRA audit krish3108 2009-05-30 08:32
- MHRA inspection Helmut 2009-05-30 13:22
- MHRA inspection vinayajadav 2009-05-30 13:49
- MHRA inspection Helmut 2009-05-30 13:22
- MHRA inspection Ohlbe 2009-05-31 00:29
- MHRA audit najatmughrabi 2009-06-01 07:28
- MHRA audit krish3108 2009-05-30 08:32
- BA/BE trials conducted in US for EMEA submission 6001 2009-05-29 21:54
- BA/BE trials conducted in US for EMEA submission Ohlbe 2009-05-30 23:49
- USFDA bioequivalence study and Non veg breakfast Avadhut 2009-05-30 16:58
- reporting of safety data such 2009-05-30 13:55
- Phenotyping & /or Genotyping joyjac 2006-06-16 02:30
- Phenotyping &/or Genotyping (single-dose BE) Helmut 2006-06-16 12:45
- Phenotyping &/or Genotyping (single-dose BE) janmacek 2009-05-27 14:14
- PMs only?! Helmut 2009-05-27 14:37
- PMs only?! janmacek 2009-05-27 15:05
- PMs only?! ElMaestro 2009-05-28 23:01
- PMs only?! janmacek 2009-05-27 15:05
- PMs only?! Helmut 2009-05-27 14:37
- Phenotyping &/or Genotyping (single-dose BE) janmacek 2009-05-27 14:14
- Phenotyping &/or Genotyping (single-dose BE) Helmut 2006-06-16 12:45
- Guidelines / Requirements for MR dosage forms Uma 2009-05-26 07:41
- Guidelines / Requirements for MR dosage forms Ohlbe 2009-05-26 09:52
- Inactive metabolite of Mycophenolate sssarker 2009-05-23 08:46
- Inactive metabolite of Mycophenolate Jaime_R 2009-05-23 12:13
- Two stage design KR 2009-05-20 11:46
- Two stage design; Bonferroni Helmut 2009-05-20 13:19
- USFDA audit Dr.Niraj Limbachiya 2009-05-19 06:35
- USFDA audit debabrata 2009-05-19 11:22
- USFDA audit Ohlbe 2009-05-19 15:51
- quantity of IPs to be retained sruman 2009-05-18 03:58
- quantity of IPs to be retained Ohlbe 2009-05-18 10:27
